Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Natural killer/T-cell lymphoma (NKTCL) is a rare subtype of non-Hodgkin lymphoma that is associated with a poor outcome. Currently, the treatment needs of NKTCL remain unmet, and efforts to further improve treatment are urgently needed. Herein, seven patients with NKTCL who failed to respond to vari...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Li, Xin, Cheng, Yasong, Zhang, Mingzhi, Yan, Jiaqin, Li, Ling, Fu, Xiaorui, Zhang, Xudong, Chang, Yu, Sun, Zhenchang, Yu, Hui, Zhang, Lei, Wang, Xinhua, Wu, Jingjing, Li, Zhaoming, Nan, Feifei, Tian, Li, Li, Wencai, Young, Ken H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793390/
https://ncbi.nlm.nih.gov/pubmed/29386072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0559-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados